CatalystFDA/Bio

ELI LILLY'S DIABETES DRUG WINS FDA APPROVAL TO LOWER HEART ATTACK AND STROKE RISK - QZ

FDA approval expands drug's use to cardiovascular risk reduction.

What changed

FDA approval expands drug's use to cardiovascular risk reduction.

Why it matters

FDA approval expands drug's use to cardiovascular risk reduction. — impact context not separately stored; see What changed.

Sources